Potential New Tourette Syndrome Treatments: Will Real-Time Neurofeedback Have a Role?

  • Barbara J. Coffey
    Address correspondence to Barbara J. Coffey, M.D., M.S., Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120 NW Fourteenth St, Ste 1455, Miami, FL 33136.
    Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hirschtritt M.E.
        • Lee P.C.
        • Pauls D.L.
        • Dion Y.
        • Grados M.A.
        • Illmann C.
        • et al.
        Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
        JAMA Psychiatry. 2015; 72: 325-333
        • Levine J.L.
        • Szejko N.
        • Bloch M.H.
        Meta-analysis: Adulthood prevalence of Tourette syndrome.
        Prog Neuropsychopharmacol Biol Psychiatry. 2019; 95: 109675
        • Cavanna A.E.
        • David K.
        • Orth M.
        • Robertson M.M.
        Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
        Eur J Paediatr Neurol. 2012; 16: 605-612
        • Tourette Association of America
        2018 impact survey findings.
        (Available at:)
        Date: 2018
        Date accessed: April 8, 2020
        • Groth C.
        • Debes N.M.
        • Skov L.
        Phenotype development in adolescents with Tourette syndrome: A large clinical longitudinal study.
        J Child Neurol. 2017; 32: 1047-1057
        • Leckman J.F.
        • Bloch M.H.
        • Smith M.E.
        • Larabi D.
        • Hampson M.
        Neurobiological substrates of Tourette’s disorder.
        J Child Adolesc Psychopharmacol. 2010; 20: 237-247
        • Yu D.
        • Sul J.H.
        • Tsetsos F.
        • Nawaz M.S.
        • Huang A.Y.
        • Zelaya I.
        • et al.
        Interrogating the genetic determinants of Tourette’s syndrome and other tic disorders through genome-wide association studies.
        Am J Psychiatry. 2019; 176: 217-227
        • Robertson M.M.
        • Eapen V.
        • Singer H.S.
        • Martino D.
        • Scharf J.M.
        • Paschou P.
        • et al.
        Gilles de la Tourette syndrome.
        Nat Rev Dis Primers. 2017; 3: 16097
        • Sukhodolsky D.G.
        • Walsh C.
        • Koller W.N.
        • Eilbott J.
        • Rance M.
        • Fulbright R.K.
        • et al.
        Randomized, sham-controlled trial of real-time functional magnetic resonance imaging neurofeedback for tics in adolescents with Tourette syndrome.
        Biol Psychiatry. 2020; 87: 1063-1070
        • Rance M.
        • Walsh C.
        • Sukhodolsky D.G.
        • Pittman B.
        • Qiu M.
        • Kichuk S.A.
        • et al.
        Time course of clinical change following neurofeedback.
        Neuroimage. 2018; 181: 807-813

      Linked Article